Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.
about
Innate immunity and inflammation in ageing: a key for understanding age-related diseasesCardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths?Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Adiposity and pathogen exposure predict C-reactive protein in Filipino women.Infectious burden and carotid plaque thickness: the northern Manhattan study.Risk factors of periodontal disease: review of the literature.The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of AtherosclerosisAn Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.An ELISA method to compute endpoint titers to Epstein-Barr virus and cytomegalovirus: application to population-based studiesFunctional and mechanistic integration of infection and the metabolic syndrome.Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markersInfectious burden: a new risk factor and treatment target for atherosclerosis.Systemic inflammation in cardiovascular and periodontal disease: comparative studyEffects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J miceSeroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TXTiming and number of minor infections as risk factors for childhood arterial ischemic stroke.Inflammatory mechanisms of stroke.Infection, inflammation, height, and longevityMicrobes, inflammation and atherosclerosis: will old pathology lessons guide new therapies?Predictors of C-reactive protein in the national social life, health, and aging projectThe role of risk factors in the development of atherosclerosis.Helicobacter pylori infection and eye diseases: a systematic review.Coagulation and thrombosis in cardiovascular disease: plausible contributions of infectious agents.Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus.Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.The role of infection in the pathogenesis of cardiovascular disease.Risk of cardiovascular events after infection-related hospitalizations in older patients on dialysisC-reactive protein concentration predicts change in body mass index during childhoodIs periodontitis associated with an increased risk of coronary heart disease and preterm and/or low birth weight births?The role of viruses in cardiac allograft vasculopathy.Understanding the expression of Toll-like receptors in Asian Indians predisposed to coronary artery disease.Chlamydia pneumoniae and coronary artery disease: legitimized linkages?Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.Biological foundation for periodontitis as a potential risk factor for atherosclerosis.Early cardiac allograft vasculopathy: are the viruses to blame?Inflammation and reactivation of latent herpesviruses in older adultsMechanisms involved in the association between periodontal diseases and cardiovascular diseasePathogen burden, cytomegalovirus infection and inflammatory markers in the risk of premature coronary artery disease in individuals of Indian origin.Genome-wide genetic investigation of serological measures of common infectionsEarly environmental factors and rheumatoid arthritis.
P2860
Q24814846-84423A23-7055-47BB-8753-4DCE8F71664DQ28069923-F49597A0-CAC4-435E-94E7-FADA15D85AACQ30319434-9B66513D-9FC2-48D5-B0CD-7049AC7D71BAQ33570915-F737A0A1-E4EC-412B-BB0E-ED4A6D21D305Q33697959-0FEB8D63-A39C-4F8A-8784-2AACFC599B38Q33746652-65E508F9-CC82-465E-9BB2-01500BEA9263Q33749010-1BEB1246-0FE5-425A-9712-D0FF28390D5BQ33763278-47D0847F-1809-4814-A1C3-8F518C16A285Q33901736-461A76D7-4C67-462E-A241-AF32D4225FF6Q33904504-BDD5CC6D-5088-4803-ABCA-E7B728267A8BQ33935504-F7879F12-6D7A-4286-918E-219DE8AA5D1AQ33936406-D9E6FD24-2096-47BE-AE9C-E6084BE96850Q33941972-DBCC130B-C299-4F99-9963-75C4F8E270C7Q34033240-B660710C-BE46-475E-8667-8A115E6390DEQ34054025-438AB9D1-1E60-48C7-8F81-215A6060FF0AQ34129790-2EAB8CFC-02AB-42D3-A7F4-01E15ADBC339Q34235537-901318A1-F9F7-444C-BF8E-556B7F67BE8BQ34249615-0D70F1A8-8A7A-4DE0-B7C6-9562EA563E35Q34286610-DA54ECD1-E5F5-4C4B-917E-8CB92B9BD96FQ34405221-C765638C-6681-483A-B525-2771B62D0500Q34447107-3EF53EB5-9651-46E0-93F1-5F6233CF32BDQ34454857-16BECD21-4E6D-4823-97DD-2C892DC76F94Q34557671-04B41828-1213-4EEC-8454-44421290B6C3Q34605079-CCD171FE-9C07-4DE6-BDCF-B73A804BDCB3Q34730407-E7DF374D-19F1-4A65-9424-2D0B240766C5Q35080677-88A6142B-2C6B-4736-B357-424616E7A53CQ35096873-7B721872-9244-4254-84BB-637C122FA508Q35112884-E7216872-DC4A-4153-95E0-EABC7F32031CQ35145332-37CB42CE-6F68-4AA3-AD21-6C7C6C827A17Q35671637-9BDFDAC0-96AA-4BE3-888F-DFE5260AE794Q35674383-264E56EE-285C-4C9A-9554-6B6C8FDFEA70Q35696285-AFD5CF71-2775-4AC4-8314-7F9874EAE3A6Q35871129-DAD29E48-7B21-48E8-BB07-79110BCA3F36Q35990885-149A414E-BA2D-4427-843D-54B051A9EB95Q36014749-AD3212E9-4C5C-4CC9-B41B-2067064CD949Q36016480-4DB2684E-8163-41BE-9DB0-0BF4DE680D6BQ36026069-7970E514-5612-4703-A080-F33A8D382FC0Q36091407-447EEF80-C4E5-4E95-95B9-54A049CFEFE7Q36184615-14E7E220-B45D-4C54-9A0F-0B750D36A02DQ36347898-C4A27948-FA22-4929-ADD2-B07BAC244FC8
P2860
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of total pathogen burd ...... and C-reactive protein levels.
@en
Effects of total pathogen burd ...... and C-reactive protein levels.
@nl
type
label
Effects of total pathogen burd ...... and C-reactive protein levels.
@en
Effects of total pathogen burd ...... and C-reactive protein levels.
@nl
prefLabel
Effects of total pathogen burd ...... and C-reactive protein levels.
@en
Effects of total pathogen burd ...... and C-reactive protein levels.
@nl
P2093
P1476
Effects of total pathogen burd ...... and C-reactive protein levels.
@en
P2093
Epstein SE
Quyyumi AA
Shearer GM
Waclawiw MA
P304
P356
10.1016/S0002-9149(99)00653-0
P407
P577
2000-01-01T00:00:00Z